SlideShare a Scribd company logo
SPECIAL SITUATIONS IN
CHILDREN WITH TYPE 1
DIABETES MELLITUS
Mohammad elsayed gharbia
INTRODUCTION
 Type 1 diabetes mellitus, one of the most
common chronic diseases in childhood, is caused
by insulin deficiency resulting from the destruction
of insulin-producing pancreatic beta cells.
 In children and adolescents with type 1 diabetes,
there are circumstances, such as :
 acute illnesses, .
 The school or daycare setting
represents challenges in the management of the
insulin- dependent child.
SICK-DAY MANAGEMENT
 In diabetic children with type 1 diabetes, acute
illness complicates diabetes management
because of its varying effects upon insulin
requirements.
 Increased insulin requirements :
are due to an increase in counter-regulatory
hormones released in response to stress.
These hormones, which include epinephrine
and cortisol, raise peripheral insulin resistance,
thereby increasing insulin requirements.
• Increased insulin resistance may persist for a
few days after recovery from the acute illness.
SICK-DAY MANAGEMENT
 Decreased insulin requirements are due to
reduced oral intake of carbohydrates because
of decreased appetite, nausea, or vomiting.
Thus, a child with type 1 diabetes during an acute
illness can develop:
 Hypoglycemia
 Significant hyperglycemia
 Diabetic ketoacidosis (DKA) due to inadequate
insulin supplementation
 Ketosis, independent of hyperglycemia
aim
 Sick-day management is directed towards
prevention of the above complications and
should not be left solely in the hands of the
child or adolescent.
 Parental involvement is imperative to avoid
these diabetic complications.
 Telephone management with the diabetes care
team is helpful in the care of these patients.
Management
 Management includes the following :
 Increased frequency of blood glucose monitoring (eg,
every two to three hours; this may be increased to
every one to two hours if necessary).
 Checking for urinary ketones with each void,
regardless of blood glucose concentration( Ketone
formation can occur without hyperglycemia, especially
if oral intake is poor).
 Home testing of blood for beta-hydroxybutyrate may
permit earlier detection of ketosis than use of urinary
strips (which measure acetone and acetoacetate).
 Blood testing for beta-hydroxybutyrate is particularly
useful for early detection of ketoacidosis in children.
hyperglycaemia
 Additional doses of rapid- or very-rapid-acting
insulin for elevated blood glucose or urine
ketones (if blood glucose is not low) .
 administering insulin at a dose of 0.05 to 0.1
units/kg (5 to 10 percent of the total daily
dose), given every two to four hours as
needed based upon blood glucose.
 administering insulin at a dose of 0.1 unit/kg
for moderate to large urinary ketones.
hypoglycaemia
 to avoid hypoglycemia : if the child is unable to ingest the required amount
of carbohydrates and blood glucose concentration is not high.
Management is dependent on the insulin regimen used by the patient.
 In children treated conventionally with a fixed schedule that includes
intermediate acting-insulin (NPH), the daily dose(s) of the intermediate-
acting insulin can be reduced by 30 to 50 percent.
 For children on intensive therapy that includes a basal dose (eg, insulin
glargine or insulin pump), the basal dose can be continued at the usual rate
or slightly decreased by 10 to 20 percent.
 In these children, insulin should not be discontinued as this may lead to
DKA, because insulin requirements, although decreased, are not
completely eliminated.
 With either regimen, increased blood glucose can be treated with rapid or
very-rapid-acting insulin .
Ketonuria
 Ketonuria with hypoglycemia is not uncommon if oral intake
has been deficient.
These patients should be treated with an increased intake of
carbohydrate-containing fluids and insulin as necessary.
 sugar-containing liquids and/or glucagon in very low doses
(0.1-0.2 mg subcutaneously every hour for up to two hours)
should be given to patients who are unable to eat and have
hypoglycemia.
 However, if vomiting persists or home therapy cannot correct
hypoglycemia, especially if ketosis is present, the patient
should be evaluated and treated at an appropriate medical
facility.
(These patients may require intravenous fluids and additional
insulin).
MEDICAL PROCEDURES
 In patients with diabetes who require medical, dental, and
surgical procedures, glycemic management can be
complicated by factors that affect insulin requirements, such
as :
 a period of medically mandated fasting (NPO),
 anesthesia,
 stress.
Withholding oral intake will decrease insulin requirements,
while stress may increase insulin needs because of increased
peripheral insulin resistance.
 If the procedure requires a period of fasting, it is preferable to
have the patient scheduled as the first case to minimize the
duration of fasting.
 Insulin management is dependent on the insulin regimen
used by the patient.
Intensive regimen
 In children using an intensive insulin regimen
with a basal insulin (eg, insulin glargine or
insulin pump), the normal basal rate should be
maintained.
 During and after the procedure, rapid- or very-
rapid-acting insulin can be used to cover
additional insulin needs as determined by
blood glucose concentrations .
 Intravenous dextrose should be administered if
blood glucose decreases.
conventional regimen
 In children using a conventional insulin regimen with an
intermediate acting-insulin (eg, NPH), :
 patients should receive 2/3 of their normal( NPH )dose and
no very-rapid or rapid-acting insulin before the procedure.
 During and after the procedure, very-rapid or rapid-acting
insulin can be used to cover additional insulin needs as
determined by blood glucose concentrations .
 During long procedures, switching from the usual
conventional regimen to infusions of intravenous insulin
administrated at a rate of 0.02 to 0.03 units/kg per hour and 5
percent dextrose with electrolytes has been used successfully
to maintain glycemic control .
 Ongoing blood glucose monitoring permits adjustment of the
insulin infusion rate to avoid hypo- or hyperglycemia.
TRAVEL
 In children who travel large distances and cross multiple time
zones, an intensive insulin basal/bolus regimen (eg, insulin
glargine with lispro/aspart or the insulin pump) simplifies care.
 The long-acting insulin (eg, insulin glargine) that provides the
basal insulin dose should continue to be administered at the
time that the child would have received this injection in his/her
home time zone.
 If the child is advancing time zones by more than two hours
for an extended time period, the family can adjust the time of
insulin glargine injections by an hour a day to a time that is
more appropriate for the new time zone.
 Very-rapid and rapid-acting insulin should continue to be
administered before meals and snacks.
 Management is more complicated in children
on conventional regimens.
 The child can receive additional doses of
very-rapid and rapid-acting insulin if the last
dose of NPH insulin does not cover the child's
insulin requirements before the next scheduled
administered NPH dose.
 During air travel, insulin supplies should be
transported as carry-on luggage.
 Insulin should be protected (but not frozen) in
a cooler during long trips where heat exposure
is likely.
 The newer insulins are particularly heat
sensitive.
SCHOOL AND DAYCARE
 Children can spend up to 8 to 10 hours a day at school or extended
daycare.
 The overall goals for children in these settings are to
1. maintain excellent glycemic control,
2.minimize interruptions of their daily learning,
3.prevent complications, and
4.prevent or eliminate any stigmatization related to their disease.
 Children must be allowed to check blood glucose levels,
 give insulin injections under the supervision of a knowledgeable
adult,
 be treated for hypoglycemia in close proximity to the school
classroom
 In one study of 58 children and their parents,
better glycemic control was demonstrated in
children who had greater flexibility in
performing diabetes care at school and
 who attended schools where school personnel
received diabetes training .
 A school staff member, preferably a school nurse
if available, needs to be identified and
appropriately trained.
 The adult supervisor is responsible for successful
implementation of daily care including :
 insulin administration,
 timing
 content of meals,
 physical education classes, and
 any additional sport activities.
 Teachers need to be able to identify and treat
hypoglycemia.
 Oral rapidly absorbed simple carbohydrates
should be available in the classroom setting.
 A glucagon emergency kit should be kept at
the school.
Thank you

More Related Content

What's hot

Hypocalcemia in paediatrics
Hypocalcemia in paediatricsHypocalcemia in paediatrics
Hypocalcemia in paediatrics
missmarimo
 
G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
HariharanK48
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
Soumya Ranjan Parida
 
Sickle cell anemia
Sickle cell anemiaSickle cell anemia
Sickle cell anemia
Anu Samuel loveusister
 
Diabetes Mellitus Type 2
Diabetes Mellitus Type 2Diabetes Mellitus Type 2
Diabetes Mellitus Type 2
AdamBilski2
 
Hypoglycaemia
HypoglycaemiaHypoglycaemia
Pharmacotherapy of diabetes mellitus
Pharmacotherapy of diabetes mellitusPharmacotherapy of diabetes mellitus
Pharmacotherapy of diabetes mellitus
Naser Tadvi
 
Hyperlipidemia
Hyperlipidemia Hyperlipidemia
Hyperlipidemia
Sagar Bagul
 
Iron metabolism final
Iron metabolism finalIron metabolism final
Iron metabolism final
sarojben
 
diabetes mellitus
 diabetes mellitus diabetes mellitus
diabetes mellitus
FREE EDUCATION FOR ALL
 
Management of megaloblastic anemia
Management of megaloblastic anemiaManagement of megaloblastic anemia
Management of megaloblastic anemia
Northen border university
 
DIABETIC KETOACIDOSIS 2023.pptx
DIABETIC KETOACIDOSIS 2023.pptxDIABETIC KETOACIDOSIS 2023.pptx
DIABETIC KETOACIDOSIS 2023.pptx
Rohit778715
 
Disorders of calcium metabolism
Disorders of calcium metabolismDisorders of calcium metabolism
Disorders of calcium metabolism
Ogechukwu Uzoamaka Mbanu
 
Pediatric obesity.,
Pediatric obesity.,Pediatric obesity.,
Pediatric obesity.,
Sayed Ahmed
 
Hyperkalemia 160108171542
Hyperkalemia 160108171542Hyperkalemia 160108171542
Hyperkalemia 160108171542
Indhu Reddy
 
Hypophosphatemia
HypophosphatemiaHypophosphatemia
Hypophosphatemia
shayiamk
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
Azad Haleem
 
Hypocalcemia 2017 case scenario
Hypocalcemia 2017 case scenarioHypocalcemia 2017 case scenario
Hypocalcemia 2017 case scenario
Yassin Alsaleh
 
IRON DEFICIENCY ANAEMIA
IRON DEFICIENCY ANAEMIAIRON DEFICIENCY ANAEMIA
IRON DEFICIENCY ANAEMIA
Agasya raj
 
Microphallus
MicrophallusMicrophallus
Microphallus
Zahoor Khan
 

What's hot (20)

Hypocalcemia in paediatrics
Hypocalcemia in paediatricsHypocalcemia in paediatrics
Hypocalcemia in paediatrics
 
G6PD deficiency
G6PD deficiencyG6PD deficiency
G6PD deficiency
 
Nephrotic syndrome
Nephrotic syndromeNephrotic syndrome
Nephrotic syndrome
 
Sickle cell anemia
Sickle cell anemiaSickle cell anemia
Sickle cell anemia
 
Diabetes Mellitus Type 2
Diabetes Mellitus Type 2Diabetes Mellitus Type 2
Diabetes Mellitus Type 2
 
Hypoglycaemia
HypoglycaemiaHypoglycaemia
Hypoglycaemia
 
Pharmacotherapy of diabetes mellitus
Pharmacotherapy of diabetes mellitusPharmacotherapy of diabetes mellitus
Pharmacotherapy of diabetes mellitus
 
Hyperlipidemia
Hyperlipidemia Hyperlipidemia
Hyperlipidemia
 
Iron metabolism final
Iron metabolism finalIron metabolism final
Iron metabolism final
 
diabetes mellitus
 diabetes mellitus diabetes mellitus
diabetes mellitus
 
Management of megaloblastic anemia
Management of megaloblastic anemiaManagement of megaloblastic anemia
Management of megaloblastic anemia
 
DIABETIC KETOACIDOSIS 2023.pptx
DIABETIC KETOACIDOSIS 2023.pptxDIABETIC KETOACIDOSIS 2023.pptx
DIABETIC KETOACIDOSIS 2023.pptx
 
Disorders of calcium metabolism
Disorders of calcium metabolismDisorders of calcium metabolism
Disorders of calcium metabolism
 
Pediatric obesity.,
Pediatric obesity.,Pediatric obesity.,
Pediatric obesity.,
 
Hyperkalemia 160108171542
Hyperkalemia 160108171542Hyperkalemia 160108171542
Hyperkalemia 160108171542
 
Hypophosphatemia
HypophosphatemiaHypophosphatemia
Hypophosphatemia
 
Insulin therapy in children.pptx
Insulin therapy in children.pptxInsulin therapy in children.pptx
Insulin therapy in children.pptx
 
Hypocalcemia 2017 case scenario
Hypocalcemia 2017 case scenarioHypocalcemia 2017 case scenario
Hypocalcemia 2017 case scenario
 
IRON DEFICIENCY ANAEMIA
IRON DEFICIENCY ANAEMIAIRON DEFICIENCY ANAEMIA
IRON DEFICIENCY ANAEMIA
 
Microphallus
MicrophallusMicrophallus
Microphallus
 

Similar to Special situations in children and adolescents with type (1) DM

Anaesthetic Management of Diabetes Mellitus in Pediatrics
Anaesthetic Management of Diabetes Mellitus in PediatricsAnaesthetic Management of Diabetes Mellitus in Pediatrics
Anaesthetic Management of Diabetes Mellitus in Pediatrics
cairo1957
 
Diabetes Information Power Point
Diabetes Information Power PointDiabetes Information Power Point
Diabetes Information Power Point
Jessica Donohue
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
MaiKhairy3
 
JDM.ppt
JDM.pptJDM.ppt
JDM.ppt
NikhilPT3
 
5809079.ppt
5809079.ppt5809079.ppt
5809079.ppt
NasserSalah6
 
Ruba presentation
Ruba presentationRuba presentation
Ruba presentation
Indhu G.P
 
H:\Diabetes In Pregnancy 1[1]
H:\Diabetes In Pregnancy 1[1]H:\Diabetes In Pregnancy 1[1]
H:\Diabetes In Pregnancy 1[1]
cslonern
 
Inpatient Diabetes
Inpatient DiabetesInpatient Diabetes
Inpatient Diabetes
albert abacan
 
Diebetes mellitus type 1
Diebetes mellitus type 1Diebetes mellitus type 1
Diebetes mellitus type 1
Priyank Ghanchi
 
Diabetes care in hospital
Diabetes care in hospitalDiabetes care in hospital
Diabetes care in hospital
Dr.Jithesh.K,MD(Med) MBA(Hosp.Admin)
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
Sabah Salim
 
Case study - DM 2, CKD 4
Case study - DM 2, CKD 4Case study - DM 2, CKD 4
Case study - DM 2, CKD 4
Reynel Dan
 
Diabetes Medications
Diabetes MedicationsDiabetes Medications
Diabetes Medications
kwelter
 
insulin pump CSII
 insulin pump CSII insulin pump CSII
insulin pump CSII
Abdo sayed
 
Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
Areej Abu Hanieh
 
Titration of insulin
Titration of insulinTitration of insulin
Titration of insulin
Apollo Hospitals
 
An update on gdm management
An update on gdm managementAn update on gdm management
An update on gdm management
namkha dorji
 
Diabetes and Telephone.pptx
Diabetes and Telephone.pptxDiabetes and Telephone.pptx
Diabetes and Telephone.pptx
dratiqur
 
JUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptxJUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptx
VIJI.V.S
 
Neonatal hypoglycemia
Neonatal hypoglycemiaNeonatal hypoglycemia
Neonatal hypoglycemia
shalu76
 

Similar to Special situations in children and adolescents with type (1) DM (20)

Anaesthetic Management of Diabetes Mellitus in Pediatrics
Anaesthetic Management of Diabetes Mellitus in PediatricsAnaesthetic Management of Diabetes Mellitus in Pediatrics
Anaesthetic Management of Diabetes Mellitus in Pediatrics
 
Diabetes Information Power Point
Diabetes Information Power PointDiabetes Information Power Point
Diabetes Information Power Point
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
JDM.ppt
JDM.pptJDM.ppt
JDM.ppt
 
5809079.ppt
5809079.ppt5809079.ppt
5809079.ppt
 
Ruba presentation
Ruba presentationRuba presentation
Ruba presentation
 
H:\Diabetes In Pregnancy 1[1]
H:\Diabetes In Pregnancy 1[1]H:\Diabetes In Pregnancy 1[1]
H:\Diabetes In Pregnancy 1[1]
 
Inpatient Diabetes
Inpatient DiabetesInpatient Diabetes
Inpatient Diabetes
 
Diebetes mellitus type 1
Diebetes mellitus type 1Diebetes mellitus type 1
Diebetes mellitus type 1
 
Diabetes care in hospital
Diabetes care in hospitalDiabetes care in hospital
Diabetes care in hospital
 
Diabetes In Pregnancy
Diabetes In PregnancyDiabetes In Pregnancy
Diabetes In Pregnancy
 
Case study - DM 2, CKD 4
Case study - DM 2, CKD 4Case study - DM 2, CKD 4
Case study - DM 2, CKD 4
 
Diabetes Medications
Diabetes MedicationsDiabetes Medications
Diabetes Medications
 
insulin pump CSII
 insulin pump CSII insulin pump CSII
insulin pump CSII
 
Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus Glycemic Control - Diabetes Mellitus
Glycemic Control - Diabetes Mellitus
 
Titration of insulin
Titration of insulinTitration of insulin
Titration of insulin
 
An update on gdm management
An update on gdm managementAn update on gdm management
An update on gdm management
 
Diabetes and Telephone.pptx
Diabetes and Telephone.pptxDiabetes and Telephone.pptx
Diabetes and Telephone.pptx
 
JUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptxJUVENILE DIABETES MELLITUS.pptx
JUVENILE DIABETES MELLITUS.pptx
 
Neonatal hypoglycemia
Neonatal hypoglycemiaNeonatal hypoglycemia
Neonatal hypoglycemia
 

Recently uploaded

share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Government Dental College & Hospital Srinagar
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 

Recently uploaded (20)

share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptxCLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 

Special situations in children and adolescents with type (1) DM

  • 1. SPECIAL SITUATIONS IN CHILDREN WITH TYPE 1 DIABETES MELLITUS Mohammad elsayed gharbia
  • 2. INTRODUCTION  Type 1 diabetes mellitus, one of the most common chronic diseases in childhood, is caused by insulin deficiency resulting from the destruction of insulin-producing pancreatic beta cells.  In children and adolescents with type 1 diabetes, there are circumstances, such as :  acute illnesses, .  The school or daycare setting represents challenges in the management of the insulin- dependent child.
  • 3. SICK-DAY MANAGEMENT  In diabetic children with type 1 diabetes, acute illness complicates diabetes management because of its varying effects upon insulin requirements.  Increased insulin requirements : are due to an increase in counter-regulatory hormones released in response to stress. These hormones, which include epinephrine and cortisol, raise peripheral insulin resistance, thereby increasing insulin requirements. • Increased insulin resistance may persist for a few days after recovery from the acute illness.
  • 4. SICK-DAY MANAGEMENT  Decreased insulin requirements are due to reduced oral intake of carbohydrates because of decreased appetite, nausea, or vomiting. Thus, a child with type 1 diabetes during an acute illness can develop:  Hypoglycemia  Significant hyperglycemia  Diabetic ketoacidosis (DKA) due to inadequate insulin supplementation  Ketosis, independent of hyperglycemia
  • 5. aim  Sick-day management is directed towards prevention of the above complications and should not be left solely in the hands of the child or adolescent.  Parental involvement is imperative to avoid these diabetic complications.  Telephone management with the diabetes care team is helpful in the care of these patients.
  • 6. Management  Management includes the following :  Increased frequency of blood glucose monitoring (eg, every two to three hours; this may be increased to every one to two hours if necessary).  Checking for urinary ketones with each void, regardless of blood glucose concentration( Ketone formation can occur without hyperglycemia, especially if oral intake is poor).  Home testing of blood for beta-hydroxybutyrate may permit earlier detection of ketosis than use of urinary strips (which measure acetone and acetoacetate).  Blood testing for beta-hydroxybutyrate is particularly useful for early detection of ketoacidosis in children.
  • 7. hyperglycaemia  Additional doses of rapid- or very-rapid-acting insulin for elevated blood glucose or urine ketones (if blood glucose is not low) .  administering insulin at a dose of 0.05 to 0.1 units/kg (5 to 10 percent of the total daily dose), given every two to four hours as needed based upon blood glucose.  administering insulin at a dose of 0.1 unit/kg for moderate to large urinary ketones.
  • 8. hypoglycaemia  to avoid hypoglycemia : if the child is unable to ingest the required amount of carbohydrates and blood glucose concentration is not high. Management is dependent on the insulin regimen used by the patient.  In children treated conventionally with a fixed schedule that includes intermediate acting-insulin (NPH), the daily dose(s) of the intermediate- acting insulin can be reduced by 30 to 50 percent.  For children on intensive therapy that includes a basal dose (eg, insulin glargine or insulin pump), the basal dose can be continued at the usual rate or slightly decreased by 10 to 20 percent.  In these children, insulin should not be discontinued as this may lead to DKA, because insulin requirements, although decreased, are not completely eliminated.  With either regimen, increased blood glucose can be treated with rapid or very-rapid-acting insulin .
  • 9. Ketonuria  Ketonuria with hypoglycemia is not uncommon if oral intake has been deficient. These patients should be treated with an increased intake of carbohydrate-containing fluids and insulin as necessary.  sugar-containing liquids and/or glucagon in very low doses (0.1-0.2 mg subcutaneously every hour for up to two hours) should be given to patients who are unable to eat and have hypoglycemia.  However, if vomiting persists or home therapy cannot correct hypoglycemia, especially if ketosis is present, the patient should be evaluated and treated at an appropriate medical facility. (These patients may require intravenous fluids and additional insulin).
  • 10. MEDICAL PROCEDURES  In patients with diabetes who require medical, dental, and surgical procedures, glycemic management can be complicated by factors that affect insulin requirements, such as :  a period of medically mandated fasting (NPO),  anesthesia,  stress. Withholding oral intake will decrease insulin requirements, while stress may increase insulin needs because of increased peripheral insulin resistance.  If the procedure requires a period of fasting, it is preferable to have the patient scheduled as the first case to minimize the duration of fasting.  Insulin management is dependent on the insulin regimen used by the patient.
  • 11. Intensive regimen  In children using an intensive insulin regimen with a basal insulin (eg, insulin glargine or insulin pump), the normal basal rate should be maintained.  During and after the procedure, rapid- or very- rapid-acting insulin can be used to cover additional insulin needs as determined by blood glucose concentrations .  Intravenous dextrose should be administered if blood glucose decreases.
  • 12. conventional regimen  In children using a conventional insulin regimen with an intermediate acting-insulin (eg, NPH), :  patients should receive 2/3 of their normal( NPH )dose and no very-rapid or rapid-acting insulin before the procedure.  During and after the procedure, very-rapid or rapid-acting insulin can be used to cover additional insulin needs as determined by blood glucose concentrations .  During long procedures, switching from the usual conventional regimen to infusions of intravenous insulin administrated at a rate of 0.02 to 0.03 units/kg per hour and 5 percent dextrose with electrolytes has been used successfully to maintain glycemic control .  Ongoing blood glucose monitoring permits adjustment of the insulin infusion rate to avoid hypo- or hyperglycemia.
  • 13. TRAVEL  In children who travel large distances and cross multiple time zones, an intensive insulin basal/bolus regimen (eg, insulin glargine with lispro/aspart or the insulin pump) simplifies care.  The long-acting insulin (eg, insulin glargine) that provides the basal insulin dose should continue to be administered at the time that the child would have received this injection in his/her home time zone.  If the child is advancing time zones by more than two hours for an extended time period, the family can adjust the time of insulin glargine injections by an hour a day to a time that is more appropriate for the new time zone.  Very-rapid and rapid-acting insulin should continue to be administered before meals and snacks.
  • 14.  Management is more complicated in children on conventional regimens.  The child can receive additional doses of very-rapid and rapid-acting insulin if the last dose of NPH insulin does not cover the child's insulin requirements before the next scheduled administered NPH dose.
  • 15.  During air travel, insulin supplies should be transported as carry-on luggage.  Insulin should be protected (but not frozen) in a cooler during long trips where heat exposure is likely.  The newer insulins are particularly heat sensitive.
  • 16. SCHOOL AND DAYCARE  Children can spend up to 8 to 10 hours a day at school or extended daycare.  The overall goals for children in these settings are to 1. maintain excellent glycemic control, 2.minimize interruptions of their daily learning, 3.prevent complications, and 4.prevent or eliminate any stigmatization related to their disease.  Children must be allowed to check blood glucose levels,  give insulin injections under the supervision of a knowledgeable adult,  be treated for hypoglycemia in close proximity to the school classroom
  • 17.  In one study of 58 children and their parents, better glycemic control was demonstrated in children who had greater flexibility in performing diabetes care at school and  who attended schools where school personnel received diabetes training .
  • 18.  A school staff member, preferably a school nurse if available, needs to be identified and appropriately trained.  The adult supervisor is responsible for successful implementation of daily care including :  insulin administration,  timing  content of meals,  physical education classes, and  any additional sport activities.
  • 19.  Teachers need to be able to identify and treat hypoglycemia.  Oral rapidly absorbed simple carbohydrates should be available in the classroom setting.  A glucagon emergency kit should be kept at the school.